ArticleThe Journal of clinical investigation2018

Dinaciclib induces immunogenic cell death and enhances anti-PD1-mediated tumor suppression.

Dewan Md Sakib Hossain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.